Literature DB >> 23100509

Bronchiolar epithelial catalase is diminished in smokers with mild COPD.

Tomoko Betsuyaku1, Satoshi Fuke, Takashi Inomata, Kichizo Kaga, Toshiaki Morikawa, Nao Odajima, Tracy Adair-Kirk, Masaharu Nishimura.   

Abstract

This study aimed to investigate bronchiolar catalase expression and its relationship with smoking and/or chronic obstructive pulmonary disease (COPD) in humans and to determine the dynamic change of bronchiolar catalase expression in response to cigarette smoke in mice. Lung tissue was obtained from 36 subjects undergoing surgery for peripheral tumours, consisting of life-long nonsmokers and smokers with or without COPD. Male C57BL/6 mice were subjected to cigarette smoke exposure for up to 3 months followed by a 28-day cessation period. We quantified bronchiolar catalase mRNA using laser capture microdissection and quantitative reverse transcription-polymerase chain reaction. C22 club cells (Clara cells) in culture were exposed to cigarette smoke extract and monitored for viability when catalase expression was decreased by siRNA. Catalase was decreased at mRNA and protein levels in bronchiolar epithelium in smokers with COPD. In mice, bronchiolar catalase is temporarily upregulated at 1 day after cigarette smoke exposure but is downregulated by repeated cigarette smoke exposure, and is not restored long after withdrawal once emphysema is developed. Decreasing catalase expression in C22 cells resulted in greater cigarette smoke extract-induced cell death. Bronchiolar catalase reduction is associated with COPD. Regulation of catalase depends on the duration of cigarette smoke exposure, and plays a critical role for protection against cigarette smoke-induced cell damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100509     DOI: 10.1183/09031936.00058912

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 2.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

3.  Identification of the key genes in chronic obstructive pulmonary disease by weighted gene co-expression network analysis.

Authors:  Zhefan Xie; Tingting Xia; Dongxue Wu; Li Che; Wei Zhang; Xingdong Cai; Shengming Liu
Journal:  Ann Transl Med       Date:  2022-06

4.  Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities.

Authors:  Abdullah Aslan; Yousif Taha Hussein; Ozlem Gok; Seda Beyaz; Orhan Erman; Serpil Baspinar
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-29       Impact factor: 4.223

5.  Nicotine alters mucin rheological properties.

Authors:  Eric Y Chen; Albert Sun; Chi-Shuo Chen; Alexander J Mintz; Wei-Chun Chin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

6.  Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study.

Authors:  Lynn Josephs; David Culliford; Matthew Johnson; Mike Thomas
Journal:  Eur Respir J       Date:  2017-05-23       Impact factor: 16.671

Review 7.  Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms.

Authors:  Adam John Anthony McGuinness; Elizabeth Sapey
Journal:  J Clin Med       Date:  2017-02-15       Impact factor: 4.241

8.  Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort.

Authors:  Rosalia Emma; Aruna T Bansal; Johan Kolmert; Craig E Wheelock; Swen-Erik Dahlen; Matthew J Loza; Bertrand De Meulder; Diane Lefaudeux; Charles Auffray; Barbro Dahlen; Per S Bakke; Pascal Chanez; Stephen J Fowler; Ildiko Horvath; Paolo Montuschi; Norbert Krug; Marek Sanak; Thomas Sandstrom; Dominick E Shaw; Louise J Fleming; Ratko Djukanovic; Peter H Howarth; Florian Singer; Ana R Sousa; Peter J Sterk; Julie Corfield; Ioannis Pandis; Kian F Chung; Ian M Adcock; René Lutter; Lorena Fabbella; Massimo Caruso
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

9.  A Polymorphism in the Catalase Gene Promoter Confers Protection against Severe RSV Bronchiolitis.

Authors:  Jeffrey M Chambliss; Maria Ansar; John P Kelley; Heidi Spratt; Roberto P Garofalo; Antonella Casola
Journal:  Viruses       Date:  2020-01-03       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.